balance 4,25 % glükoos, 1,25 mmol/l kaltsium peritoneaaldialüüsilahus
fresenius medical care deutschland gmbh - hüpertoonilised lahused - peritoneaaldialüüsilahus - 3000ml 4tk; 2000ml 4tk; 2500ml 4tk; 6000ml 2tk; 1500ml 4tk; 5000ml 2tk
valarox õhukese polümeerikattega tablett
krka, d.d., novo mesto - rosuvastatiin+valsartaan - õhukese polümeerikattega tablett - 10mg+80mg 100tk; 10mg+80mg 14tk; 10mg+80mg 10tk; 10mg+80mg 30tk; 10mg+80mg 84tk; 10mg+80mg 20tk
enalapril-ratiopharm 20mg tablett
ratiopharm gmbh - enalapriil - tablett - 20mg 50tk; 20mg 30tk; 20mg 100tk
balance 2,3 % glükoos, 1,75 mmol/l kaltsium peritoneaaldialüüsilahus
fresenius medical care deutschland gmbh - hüpertoonilised lahused - peritoneaaldialüüsilahus - 6000ml 2tk
balance 4,25 % glükoos, 1,75 mmol/l kaltsium peritoneaaldialüüsilahus
fresenius medical care deutschland gmbh - hüpertoonilised lahused - peritoneaaldialüüsilahus - 2500ml 4tk; 5000ml 2tk; 3000ml 4tk; 6000ml 2tk
valarox õhukese polümeerikattega tablett
krka, d.d., novo mesto - rosuvastatiin+valsartaan - õhukese polümeerikattega tablett - 20mg+80mg 56tk; 20mg+80mg 60tk; 20mg+80mg 90tk; 20mg+80mg 14tk; 20mg+80mg 20tk; 20mg+80mg 30tk; 20mg+80mg 28tk
balance 1,5 % glükoos, 1,75 mmol/l kaltsium peritoneaaldialüüsilahus
fresenius medical care deutschland gmbh - hüpertoonilised lahused - peritoneaaldialüüsilahus - 3000ml 4tk; 5000ml 2tk
balance 2,3 % glükoos, 1,25 mmol/l kaltsium peritoneaaldialüüsilahus
fresenius medical care deutschland gmbh - hüpertoonilised lahused - peritoneaaldialüüsilahus - 5000ml 2tk
enalapril-ratiopharm 10mg tablett
ratiopharm gmbh - enalapriil - tablett - 10mg 50tk; 10mg 100tk
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastilised ained - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.